What changed from existing technology?
This study looked at how smoking affects men with advanced prostate cancer, finding that smoking might be linked to more aggressive cancer changes and worse outcomes.
This study is the first to link smoking with specific genetic changes in metastatic prostate cancer that may influence disease progression and treatment response.
Commercialization signals visible at publication
This is not a success probability or investment opinion. It prioritizes follow-up using evidence available when the paper was published.
Verified evidence · 1
atabase for this retrospective analysis. We associated patient characteristics and tumor genetic data with smoking exposure at diagnosis (current, former, ne
Abstract ↗- 시제품·장치 구현 근거 미확인
- 제조·규모 확장 근거 미확인
Later patent, company, clinical, and production events are added separately only after verification.
Patent check: Not checked yetCurrent technology stage: Near commercialization
See what changed before reading the full paper.
What still needs to be solved?
Repeated real-world validation, manufacturability, cost, and long-term stability still require follow-up evidence.
What could change if this succeeds?
This research suggests that smoking may influence the genetic profile of metastatic prostate cancer, potentially affecting treatment strategies and prognosis.
Keep following this technology
Revisit changes when new papers, patents, company participation, validation, or products appear.